Article 23 Apr 2026 Differential Impact of Metabolic Bariatric Surgery Versus Semaglutide on Hepatic and Extrahepatic Outcomes in MASLD and Type 2 Diabetes Manuscript Summaries
Article 23 Apr 2026 Semaglutide Treatment in Type 2 Diabetes: Unveiling Its Impact on Liver Cirrhosis and Hepatocellular Carcinoma Manuscript Summaries
Article 23 Apr 2026 Incretin and Glucagon Signalling: A Metabolic Symphony in MASLD and MASH Management Manuscript Summaries
Article 7 Apr 2026 Unraveling MASLD: The Crucial Intersection of Obesity and Metabolic Dysfunction in Liver Disease Manuscript Summaries
Article 1 Apr 2026 Type 2 diabetes subphenotypes are associated with differential outcomes after metabolic and bariatric surgery: An international multicentre retrospective cohort study Manuscript Summaries
Article 1 Apr 2026 Current Trends in the Epidemiology of Obesity and theAssociation Between Obesity and Metabolic Liver Disease(MASLD/MASH) Manuscript Summaries
Article 14 Feb 2026 Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Manuscript Summaries
Article 5 Sep 2025 Novel Serum Biomarkers for Diagnosing MASLD in Adolescents: A Comparative Clinical Study Manuscript Summaries
Article 5 Sep 2025 Naltrexone-Bupropion in Type 2 Diabetes: A Weight Loss Strategy with Measurable Benefits for MASLD and Liver Health Manuscript Summaries
